Promedigen - Crunchbase Company Profile & Funding

Q: Who invested in Promedigen?

Promedigen is funded by Company K Partners.

Q: When was the last funding round for Promedigen?

Promedigen closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Promedigen

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Promedigen

CB Rank

444665

Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.

Founded

obfuscation

Private

Venture - Series Unknown

Daejeon, Taejon-jikhalsi, South Korea

11-50

www.promedigen.com

Biotechnology

Neuroscience

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

Promedigen Co., Ltd.

Operating Status

Active

Company Type

For Profit

Phone Number

+82 42 867 9113

Contact Email

contact@promedigen.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PMG-A3

A drug candidate that activates tumor suppressor proteins to induce cancer cell death and control drug resistance factors.

Proprietary Protein Engineering Platform for Site-Specific Post-Translational Modifications (PTMs)

A technology platform enabling the production of proteins with site-specific post-translational modifications to study disease-related protein interactions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Promedigen	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Company K Partners	—	Venture Round - Promedigen	—
Company K Partners	—	Venture Round - Promedigen	—
Company K Partners	—	Venture Round - Promedigen	—
Company K Partners	—	Venture Round - Promedigen	—
Company K Partners	—	Venture Round - Promedigen	—